欧美欧洲成 人在线观看_印度AV无码Av乱码在线_美大色堂在线视频_人人五级片在线播放

        Zhongshan Belling Biotechnology Co., Ltd., was founded in 2004 and located in Health Industry Base of Zhongshan City, Guangdong Province, is committed to the R&D and production of active pharmaceutical ingredient, high-purity animal and plant extracts, cosmetic raw materials and food additives as well. Through two decades of relentless efforts, Bellingbio has developed seven major bile acid APIs, with Ursodeoxycholic Acid (UDCA) and Chenodeoxycholic Acid (CDCA) as the two flagship products. Bellingbio also has established a library of more than 100 bile acid component structures and a reference standard library of more than 50 bile acid components, made outstanding achievements in the field of bile acid APIs and laid a solid foundation for other types of APIs. Commercial products and campaign products are advancing in tandem, contributing to the construction and protection of human health with Bellingbio's strength. At present, Bellingbio has the   largest production base for Ursodeoxycholic Acid and Chenodeoxycholic Acid APIs in China. In the sub-industry of bile acid products, Bellingbio occupies the first position in the domestic market share and within the top three positions in the international market share.

        In 2010, Bellingbio passed the GMP certification, and our products have been successively approved by official registrations in China, the European Union, Japan, South Korea, Russia, India, and Bangladesh. In 2019, Bellingbio also passed the on-site inspection by the US FDA. In 2019 and 2022, Bellingbio respectively obtained the CEP certificates for Ursodeoxycholic Acid API with chemical and enzymatic process. Bellingbio's mature production process and strict quality control ensure that each batch of products meets the quality standards of various countries and customers, such as the Chinese Pharmacopoeia (CP), European Pharmacopoeia (EP), United States Pharmacopeia (USP), Japanese Pharmacopoeia (JP), and other mainstream regional and national pharmacopoeia standards.

        Bellingbio not only focuses on the growth and development of the enterprise but also pays much attention to the social responsibility. Over the two decades, Bellingbio has accumulated more than 200 million yuan in tax payments and has been recognized by governments at all levels, obtaining the titles such as "Pioneering Enterprise" and "Leading Enterprise" in Health Industry Base of Zhongshan City. In addition, Bellingbio is committed to promoting the environmentally friendly production process for reducing waste emissions and lowering energy consumption, adheres to environment-friendly green development. At the same time, Bellingbio actively participates in social welfare activities, donates to education, and participates in the charity of the Red Cross as well, repaying society with practical actions and conveying love and warmth.

        Over the course of two decades, Bellingbio has embodied its original aspirations and fulfilled its mission through action. In the future, Bellingbio will continue to take courage as soul, be loyal and righteous, and strive for excellence. With commitment to quality, research and development, service, and responsibility, Bellingbio will continue to forge ahead in the market, striving to become a professional and global supplier of high-quality bio-pharmaceutical products supplier with "leading technology, leading quality, leading market, leading service".